Literature DB >> 15128770

Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen.

Tse-Ching Chen1, Stephen P Cobbold, Paul J Fairchild, Herman Waldmann.   

Abstract

Regulatory CD4(+) T cells are known to develop during the induction of donor-specific peripheral tolerance to transplanted tissues; it is proposed that such tolerance is a consequence of persistent, danger-free stimulation by Ag. To test this hypothesis, male RAG-1(-/-) mice were recolonized with small numbers of monospecific CD4(+) T cells specific for the male H-2E(k)-restricted Ag Dby. After 6 wk in the male environment, the monospecific CD4(+) T cells, having recolonized the host, had become anergic to stimulation in vitro and had acquired a regulatory capacity. CD4(+) T cells in these mice expressed higher levels of CTLA-4 and glucocorticoid-induced TNF-related receptor than naive CD4(+) T cells, but only 3% of the recolonizing cells were CD25(+) and did not express significant foxP3 mRNA. In vivo, these tolerant T cells could censor accumulation of, and IFN-gamma production by, naive T cells, with only a slight inhibition of proliferation. This suppressive effect was not reversed by the addition of fresh bone marrow-derived male dendritic cells. These results suggest that persistent exposure to Ag in conditions that fail to evoke proinflammatory stimuli leads to the development of T cells that are both anergic and regulatory.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128770     DOI: 10.4049/jimmunol.172.10.5900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  At low precursor frequencies, the T-cell response to chronic self-antigen results in anergy without deletion.

Authors:  Elizabeth M Steinert; Ronald H Schwartz; Nevil J Singh
Journal:  Eur J Immunol       Date:  2012-09-12       Impact factor: 5.532

Review 2.  Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.

Authors:  Kirsty S Nicolson; David C Wraith
Journal:  Inflamm Allergy Drug Targets       Date:  2006-09

Review 3.  Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance.

Authors:  Su M Metcalfe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 4.  T cell tolerance induced by therapeutic antibodies.

Authors:  Stephen P Cobbold
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

5.  Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells.

Authors:  S Alice Long; Mary Rieck; Megan Tatum; Paul L Bollyky; Rebecca P Wu; Isabelle Muller; Jhon-Chun Ho; Heather G Shilling; Jane H Buckner
Journal:  J Immunol       Date:  2011-08-24       Impact factor: 5.422

6.  Regulatory T cells in renal disease.

Authors:  Yuan Min Wang; Min Hu; Ya Wang; Tania Polhill; Geoff Yu Zhang; Yiping Wang; Vincent W S Lee; David C H Harris; Stephen I Alexander
Journal:  Int J Clin Exp Med       Date:  2008-08-20

7.  Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression.

Authors:  Panayotis Verginis; Katherine A McLaughlin; Kai W Wucherpfennig; Harald von Boehmer; Irina Apostolou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

8.  Dynamics of human regulatory T cells in lung lavages of lung transplant recipients.

Authors:  David C Neujahr; Adriana C Cardona; Onome Ulukpo; Mark Rigby; Andres Pelaez; Allan Ramirez; Anthony A Gal; Seth D Force; E Clinton Lawrence; Allan D Kirk; Christian P Larsen
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

Review 9.  How do regulatory T cells work?

Authors:  A Corthay
Journal:  Scand J Immunol       Date:  2009-10       Impact factor: 3.487

10.  Anti-CD4-mediated selection of Treg in vitro - in vitro suppression does not predict in vivo capacity to prevent graft rejection.

Authors:  Vanessa Oliveira; Birgit Sawitzki; Stephanie Chapman; Christine Appelt; Inga Gebuhr; Joanna Wieckiewicz; Elaine Long; Kathryn J Wood
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.